Manchester Cancer Research Centre shared a post on LinkedIn:
“New PhD Opportunity
How can we make life-saving cancer treatments even safer for children?
We are looking for a motivated researcher to join The University of Manchester and The Christie NHS Foundation Trust to assess the benefits of adaptive proton therapy in paediatric and young adult patients.
Proton therapy is a game-changer for young patients, but anatomical changes during treatment can impact precision. This project aims to develop AI-driven, adaptive strategies to ensure the highest level of safety and effectiveness, minimizing long-term side effects and protecting normal growth.
Application Deadline: 9 February 2026
Location: Manchester, UK
Full details and application.”
More from Manchester Cancer Research Centre on OncoDaily.